CORC  > 四川大学
Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
Ben-Xu Tan MD; Wen-Xiu Yao MD; Jun Ge MD; Xing-Chen Peng MD; Xiao-Bo Du MD; Ru Zhang MD; Bin Yao MD; Ke Xie MD; Long-Hao Li MD; Hang Dong MD
刊名Cancer
2011
卷号Vol.117 No.22页码:5103-5111
关键词metformin insulin nonsmall cell lung cancer diabetes chemotherapy
ISSN号0008-543X
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/1996228
专题四川大学
作者单位1.Department of Geratology, General Hospital of the People's Liberation Army Chengdu Military Region, Chengdu, China
2.Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China
3.Department of Oncology, Mianyang Central Hospital, Mianyang, China
4.Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, China
5.Department of Oncology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Chengdu, China
推荐引用方式
GB/T 7714
Ben-Xu Tan MD,Wen-Xiu Yao MD,Jun Ge MD,et al. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes[J]. Cancer,2011,Vol.117 No.22:5103-5111.
APA Ben-Xu Tan MD.,Wen-Xiu Yao MD.,Jun Ge MD.,Xing-Chen Peng MD.,Xiao-Bo Du MD.,...&Ji-Yan Liu MD.(2011).Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.Cancer,Vol.117 No.22,5103-5111.
MLA Ben-Xu Tan MD,et al."Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes".Cancer Vol.117 No.22(2011):5103-5111.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace